Write in a clean editor, then format for Journal of Cellular Immunotherapy in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Cellular Immunotherapy is a peer-reviewed journal published by Elsevier, covering Diverse Scientific and Economic Studies, MicroRNA in disease regulation, Immunotherapy and Immune Responses.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Cellular Immunotherapy 12 (2023) 45–58.
Formats any DOI in Journal of Cellular Immunotherapy style. No sign-up. |
| Publishes research in | Diverse Scientific and Economic Studies MicroRNA in disease regulation Immunotherapy and Immune Responses Nutrition, Genetics, and Disease RNA Interference and Gene Delivery |
| ISSN | 2352-1775 |
| h-index | 12 |
| i10-index | 12 |
| Total citations | 990 |
| Top institutions publishing here | Mashhad University of Medical Sciences |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Mesenchymal stem cells (MSCs) represent a heterogenous population of adult, fibroblast-like multi-potent cells. MSCs have drawn much attention during the last decade in the field of regenerative medicine, mainly due to their capacity to differentiate into specific cell types, abundant production of soluble growth factors and cytokines, and hematopoiesis supporting properties. In addition, MSCs can…
Adoptive immunotherapy with T cells expressing a tumor-associated chimeric antigen receptor (CAR) provides a promising approach for tumor therapy. We designed a clinical trial for multiple myeloma (MM) treatment with CAR-modified T cells recognizing CD138 (CART-138). Five patients diagnosed with chemotherapy-refractory MM were enrolled into this trial, although one later advanced to plasma cell leukemia…
This paper will summarize the data obtained primarily from the last decade of chimeric antigen receptor (CAR) T cell immunotherapy. It will do so in a manner that provides an overview needed to set the foundation for perspective on the state of research associated with CAR T cell therapy. The topics covered will include the…
Increasing attention has been given to the tumor microenvironment (TME), which includes cellular and structural components such as fibroblasts, immune cells, vasculature, and extracellular matrix (ECM) that surround tumor sites. These components contribute to tumor growth and metastasis and are one reason why traditional chemotherapy often is insufficient to eradicate the tumor completely. Newer treatments…
Multiple Sclerosis (MS) is a multifactorial disease with several physiologic and pathogenic mechanisms and pathways. In MS the immune system attacks the myelin sheath that provides insulation to the nerve cells in their brain, spinal cord and optic nerve. With the damaged and compromised nerve membrane, the nerve cells are not able to conduct electrical…
